Cannabinoides
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (11)
2023
-
Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43
Neuropharmacology, Vol. 240
2022
-
Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse
Frontiers in Neuroanatomy, Vol. 16
-
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice
Cell Death and Disease, Vol. 13, Núm. 7
2021
-
Δ9-Tetrahydrocannabinol promotes functional remyelination in the mouse brain
British Journal of Pharmacology, Vol. 178, Núm. 20, pp. 4176-4192
-
Δ9-Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo
GLIA, Vol. 69, Núm. 3, pp. 532-545
2020
-
Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer
The Journal of experimental medicine, Vol. 217, Núm. 6
2017
-
Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization
Clinical Endocrinology, Vol. 86, Núm. 6, pp. 778-783
2016
2015
-
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects
Journal of Psychopharmacology, Vol. 29, Núm. 11, pp. 1137-1145
-
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects
Addiction Biology, Vol. 20, Núm. 4, pp. 773-783